APP Causes Hyperexcitability in Fragile X Mice
Amyloid-beta protein precursor (APP) and metabolite levels are altered in fragile X syndrome (FXS) patients and in the mouse model of the disorder, Fmr1KO mice. Normalization of APP levels in Fmr1KO mice (Fmr1KO/APPHET mice) rescues many disease phenotypes. Thus, APP is a potential biomarker as well...
Main Authors: | Cara Jean Westmark, Shih-Chieh Chuang, Seth A Hays, Mikolaj J Filon, Brian C Ray, Pamela R Westmark, Jay R Gibson, Kimberly M Huber, Robert KS Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-12-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00147/full |
Similar Items
-
Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
by: Pamela R. Westmark, et al.
Published: (2021-10-01) -
Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome
by: Sonal Goswami, et al.
Published: (2019-04-01) -
Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
by: Cara J. Westmark, et al.
Published: (2020-08-01) -
Developing BACE-1 inhibitors for FXS
by: Cara J Westmark, et al.
Published: (2013-05-01) -
The role of Fragile X mental retardation protein in Drosophila cleavage furrow formation
by: Monzo, Kate Frances
Published: (2010)